CNS Summit 2022

CNS創薬の技術と科学に100%専心

We know that no other area of medical research requires as much rigor and inventiveness as CNS Clinical Development.

Our team of nearly 1,600 experts is the first and only fully dedicated CNS business unit in the CRO world, robustly resourced to support your CNS drug development success, no matter how big or small your organization. Our CNS-experienced clinical leaders will provide you with deep therapeutic knowledge, hands-on trial experience, financial understanding and strong leadership and partnering skills, on every step of your CNS journey.

Be sure to find us on the floor at CNS Summit 2022, at booth #52

FEATURED PANEL:

Fireside Chat

Michelle Keefe
CEO, Syneos Health

Friday November 18 | Time: TBD

詳細に興味がおありですか？ Explore Insights Hub

or click on the resources below:

Neuroscience: Accelerate Your Drug Development Success to Patients in Need

Cell and Gene Therapy Consortium Fact Sheet

Syneos Health Podcast: Opportunities and Challenges in Cell and Gene Therapy

Designing Gene Therapy Study Protocols Based on Patient Burden Scores

サイネオス・ヘルスのポッドキャスト：プラセボ効果

てんかんの臨床試験における課題とチャンス

Advanced Therapy Medicinal Product (ATMP) Clinical Trials: Navigating Recent Scientific and Regulatory Rules of the Road in the US and EU